Gayle Deflin - Jun 5, 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Jun 5, 2023
Transactions value $
$0
Form type
4
Date filed
6/7/2023, 05:18 PM
Previous filing
May 19, 2023
Next filing
Nov 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +2.72K +65.24% $0.00 6.88K Jun 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Award $0 +7.02K $0.00 7.02K Jun 5, 2023 Common Stock 7.02K $46.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 5, 2024.
F2 All of the shares subject to the option vest on June 5, 2024.